Skip to main content

Table 1 Study population

From: Inter-observer agreement and diagnostic accuracy of myocardial perfusion reserve quantification by cardiovascular magnetic resonance at 3 Tesla in comparison to quantitative coronary angiography

 

N = 53

Age, years

63.0 ± 9.3

Female gender, female (%)

17 (32.1)

Body mass index, kg/m2

27.4 ± 3.5

Cardiovascular risk factors

 

 Hypertension, N (%)

42 (79.2)

 Hypercholesterolemia, N (%)

36 (67.9)

 Diabetes, N (%)

11 (20.8)

 Smoking, N (%)

8 (15.1)

 Framingham 10 years risk,%

13 ± 7

History of coronary artery disease

 

 Known coronary artery disease, N (%)

34 (64.2)

 Known myocardial infarction, N (%)

18 (34.0)

Medication

 

 β- Blocker, N (%)

34 (64.2)

 AT1-Inhibitor/ACE-Inhibitor, N (%)

39 (73.6)

 Statin, N (%)

40 (75.5)

 Platelet aggregation inhibitor, N (%)

46 (86.8)

Ventricular volumes and function

 

 Left ventricular ejection fraction,%

61 ± 9

 Left ventricular end-diastolic volume index, ml/m2

81 ± 15

 Left ventricular mass index, g/m2

54 ± 10

 Right ventricular ejection fraction,%

63 ± 6

 Right ventricular end-diastolic volume index, ml/m2

72 ± 14

Quantitative coronary angiography

 

 Patients with stenosis ≥ 70%, N (%)

25 (47.2)

 1-vessel disease

15 (28.3)

 Multi-vessel disease

10 (18.9)